HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cetuximab for colorectal cancer.

AuthorsFilippo Fraggetta, Giuseppe Pelosi
JournalThe New England journal of medicine (N Engl J Med) Vol. 358 Issue 11 Pg. 1196; author reply 1196-7 (Mar 13 2008) ISSN: 1533-4406 [Electronic] United States
PMID18340663 (Publication Type: Letter, Comment)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Biomarkers
  • ErbB Receptors
  • Cetuximab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents (therapeutic use)
  • Biomarkers (metabolism)
  • Cetuximab
  • Colorectal Neoplasms (drug therapy)
  • ErbB Receptors (immunology, metabolism)
  • Humans
  • Immunohistochemistry
  • Neoplasm Metastasis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: